EP Patent

EP1060741A1 — Sustained release microspheres

Assigned to Baxter Healthcare SA · Expires 2000-12-20 · 25y expired

What this patent protects

Methods for forming sustained release microspheres and the products produced thereby are provided. The microspheres have a smooth surface that includes a plurality of channel openings that are less than 1000 angstroms in diameter.

USPTO Abstract

Methods for forming sustained release microspheres and the products produced thereby are provided. The microspheres have a smooth surface that includes a plurality of channel openings that are less than 1000 angstroms in diameter.

Drugs covered by this patent

Patent Metadata

Patent number
EP1060741A1
Jurisdiction
EP
Classification
—
Expires
2000-12-20
Drug substance claim
No
Drug product claim
No
Assignee
Baxter Healthcare SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.